Cerebrolysin vs NSI-189
Overview
Cerebrolysin and NSI-189 are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares Cerebrolysin and NSI-189 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Cerebrolysin | NSI-189 | |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Regulatory status (US) | Research use only | Research use only |
| Typical dosage | 5-10 ml | Research protocols vary |
| Frequency | multiple times weekly | research |
| Reported benefits | Neuroprotection, stroke recovery support, cognitive improvement, neurodegenerative disease support | Hippocampal growth, potential depression treatment, cognitive enhancement |
| Reported side effects | Generally well-tolerated. Possible: dizziness, agitation | Experimental. Side effects under investigation |
Key differences
Primary use. Cerebrolysin is categorised under Cognitive Enhancement, while NSI-189 falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. Cerebrolysin: not FDA-approved; treated as a research compound. NSI-189: not FDA-approved; treated as a research compound.
Dosing. Cerebrolysin is typically dosed at 5-10 ml (multiple times weekly). NSI-189 is typically dosed at Research protocols vary (research).
Can you stack them?
Some protocols combine peptides, but stacking Cerebrolysin and NSI-189 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Cerebrolysin and NSI-189?
- Cerebrolysin and NSI-189 are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. Cerebrolysin is not FDA-approved; generally classified as a research compound, whereas NSI-189 is not FDA-approved; generally classified as a research compound.
- What is Cerebrolysin used for?
- Neuroprotection, recovery.
- What is NSI-189 used for?
- Neurogenesis, depression.
- Can you take Cerebrolysin and NSI-189 together?
- Some users combine peptides within a single protocol, but stacking Cerebrolysin and NSI-189 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Cerebrolysin or NSI-189 FDA-approved?
- Cerebrolysin is not FDA-approved; generally classified as a research compound. NSI-189 is not FDA-approved; generally classified as a research compound.
Read the full articles
- Cerebrolysin — full monograph: mechanism, research, dosing & references
- NSI-189 — full monograph: mechanism, research, dosing & references